Inhibitor Therapeutics (INTI) Research & Development (2013 - 2026)
Inhibitor Therapeutics' Research & Development was $223,564 in Q2 2026, down 31.3% from $325,623 a year earlier and down 34.4% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Research & Development (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Inhibitor Therapeutics' Research & Development was $1.7 million through Jun 30, 2026, down 6.6% year-over-year; for FY2025, it was $1.7 million, down 3.5% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 55.7% (FY2020 to FY2025).
- In earlier years, Research & Development was $1.76 million in FY2024 (+27.3%), $1.38 million in FY2023, $6,150 in FY2022 (+25.4%) and $4,905 in FY2021 (-97.4%).
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q1 2023.
- Compared with a year earlier, Research & Development was higher in five of the last eight quarters, with growth averaging 12.3%.
- The best year-over-year quarter for Research & Development over five years was Q2 2022 (growth of 547.4%); the worst was Q4 2021 (a decline of 97.2%).
- Per Business Quant data, INTI's Research & Development in the three quarters before Q2 2026 was $340,562 (Q1 2026), $757,248 (Q4 2025) and $377,789 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 223,564.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223,564.00 |
| Mar 31, 2026 | 340,562.00 |
| Dec 31, 2025 | 757,248.00 |
| Sep 30, 2025 | 377,789.00 |
| Jun 30, 2025 | 325,623.00 |
| Mar 31, 2025 | 236,058.00 |
| Dec 31, 2024 | 887,794.00 |
| Sep 30, 2024 | 369,621.00 |
| Jun 30, 2024 | 239,776.00 |
| Mar 31, 2024 | 260,359.00 |
| Dec 31, 2023 | 684,910.00 |
| Sep 30, 2023 | 260,765.00 |
| Jun 30, 2023 | 233,993.00 |
| Mar 31, 2023 | 201,398.00 |
| Jun 30, 2022 | 6,150.00 |
| Dec 31, 2021 | 75.00 |
| Jun 30, 2021 | 950.00 |
| Mar 31, 2021 | 3,880.00 |
| Dec 31, 2020 | 2,710.00 |
| Sep 30, 2020 | 32,468.00 |
API Access
Inhibitor Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();